论文信息 - CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL - 字舞流文

CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL

M. Uhrberg | S. Bhatia | D. Vallera | M. Felices | F. Babor | A. Manser | Jeffrey S. Miller | Sarah B. Reusing | Titus Vatrin